Microbot Medical granted Chinese patent; issues 1.48M shares for $2.22M

Microbot Medical Inc.

China National IP Administration granted patent covering robotic manipulation of surgical tool handle.
LIBERTY System now has nine global patents granted and 59 patent applications pending.
Since May 13, 2025, issued 1.48M shares upon exercise of Series E/F options at $1.50, raising ~$2.22M gross.
Anticipated U.S. commercial launch of LIBERTY in Q3 2025, pending FDA 510(k) clearance, preparations accelerating.
Patent supports global IP strategy; China estimated ~2.9M peripheral endovascular procedures annually.

item 3.02item 7.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.